13.8 C
Austin
Saturday, January 18, 2025

CATEGORY

Drugs

NIH Discontinues their Drug Interaction API

Recently, the NIH announced it is discontinuing its drug-drug interaction API and associated features in RxNav. Up until now, DrugBank’s data has fed directly...

BioTechX USA. No.1 in our Hearts

Earlier this month, a cohort of our team packed our bags and headed to California for the inaugural BioTechX USA. As a distributed team,...

More Powerful Clinical Trials Data Is Here

ClinicalTrials.gov is a vital, go-to resource for information about clinical trials. It contains more than 450,000 studies from over 200 countries. However, extracting insights...

New Rare Disease Dataset Just Dropped

At any given time, millions of people (3.5–5.9% of the global population) suffer from rare conditions without effective treatments or cures. Rare diseases, therefore,...

Precision Medicine in the Genomic Era

Precision medicine, sometimes referred to as “personalized medicine,” is an increasingly common term that remains difficult to precisely define, in spite of its popularity....

BioIT World Conference and Expo 2023

In the middle of May, we packed up our bags, our conference booth, and one USB stick with a presentation about the future of...

How keeping an eye on culture helped us grow sustainably

From the beginning, DrugBank worked to be a people-centered organization. As a bootstrapped startup we relied solely on revenue to grow our team. We...

We’re in this together: Achieve your goals faster with DrugBank on your side

The moment you decide which DrugBank license or products best suit your needs isn’t the final step in our relationship, it is just the...

Leverage DrugBank: Target Data

DrugBank's deep pool of drug knowledge can be used for everything from AI in drug discovery to In Silico, Precision Medicine, and so much...

Precision Medicine World Conference 2023

As the snow was falling on us at the end of January a handful of our team packed their bags and flew down to...

Latest news